Related Experiment Video
Updated: May 7, 2026

06:24
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
10.0K
High-cell-density fed-batch strategy to manufacture tailor-made P(HB-co-HHx) by engineered Ralstonia eutropha at
Isabel Thiele1, Lara Santolin1, Svea Detels1
1Chair of Bioprocess Engineering, Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany.
Microbial Biotechnology
|June 8, 2024
Summary
Developing efficient bioprocesses is key for sustainable plastics. This study optimized polyhydroxyalkanoates (PHA) production, enabling tailored biodegradable plastics at scale.
Area of Science:
- Biotechnology and Bioprocess Engineering
- Polymer Science
- Sustainable Materials
Background:
- The transition to a bioeconomy necessitates cost-effective bioprocesses for bulk material production.
- Polyhydroxyalkanoates (PHAs) are biobased and biodegradable plastics with tunable properties.
- Poly(hydroxybutyrate-co-hydroxyhexanoate) (P(HB-co-HHx)) offers desirable material characteristics modulated by monomer composition.
Purpose of the Study:
- To develop a high-cell-density fed-batch strategy for producing P(HB-co-HHx) with controlled composition.
- To scale up the production process from laboratory to pilot scale.
- To enable the kilogram-scale production of PHA bioplastics with specific material properties.
Main Methods:
- Utilized a high-cell-density fed-batch strategy with fructose and canola oil mixtures.
- Employed Ralstonia eutropha Re2058/pCB113 for P(HB-co-HHx) production.
- Scaled the process from 1-L laboratory to 150-L pilot scale.
Main Results:
- Achieved cell densities exceeding 100 g/L.
- Produced PHA containing 70-80 wt% polymer.
- Tuned HHx content in the range of 9.0-14.6 mol%.
- Reached productivities up to 1.5 g/L/h.
- Demonstrated tailor-made P(HB-co-HHx) production at an industrially relevant scale.
Conclusions:
- The developed fed-batch strategy enables the tailor-made production of P(HB-co-HHx) at an industrially relevant scale.
- This approach facilitates kilogram-scale production of PHA bioplastics with defined material properties.
- The strategy supports the commercialization of PHA as a sustainable alternative to conventional plastics.
More Related Videos
Related Concept Videos
Bioreactor Design and Operational System
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
Fed-Batch Culture
Fed-batch culture is a widely used bioprocessing strategy combining aspects of batch culture with controlled substrate feeding to optimize cell growth and product formation. In this semi-closed system, nutrients are strategically added during fermentation, while the accumulated products and biomass remain within the bioreactor until the end of the operation. This controlled addition of substrates allows for better management of growth kinetics, nutrient limitation, and metabolite...
Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

